rs11620036
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005932.4(MIPEP):c.1970+20A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 1,613,020 control chromosomes in the GnomAD database, including 56,181 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.20 ( 3814 hom., cov: 32)
Exomes 𝑓: 0.26 ( 52367 hom. )
Consequence
MIPEP
NM_005932.4 intron
NM_005932.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.497
Publications
6 publications found
Genes affected
MIPEP (HGNC:7104): (mitochondrial intermediate peptidase) The product of this gene performs the final step in processing a specific class of nuclear-encoded proteins targeted to the mitochondrial matrix or inner membrane. This protein is primarily involved in the maturation of oxidative phosphorylation (OXPHOS)-related proteins. This gene may contribute to the functional effects of frataxin deficiency and the clinical manifestations of Friedreich ataxia. [provided by RefSeq, Jul 2008]
MIPEP Gene-Disease associations (from GenCC):
- lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Broad Center for Mendelian Genomics
- mitochondrial diseaseInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 13-23760076-T-G is Benign according to our data. Variant chr13-23760076-T-G is described in ClinVar as [Benign]. Clinvar id is 1259605.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.203 AC: 30904AN: 151920Hom.: 3816 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
30904
AN:
151920
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.201 AC: 50414AN: 251136 AF XY: 0.208 show subpopulations
GnomAD2 exomes
AF:
AC:
50414
AN:
251136
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.258 AC: 377565AN: 1460982Hom.: 52367 Cov.: 33 AF XY: 0.257 AC XY: 186513AN XY: 726838 show subpopulations
GnomAD4 exome
AF:
AC:
377565
AN:
1460982
Hom.:
Cov.:
33
AF XY:
AC XY:
186513
AN XY:
726838
show subpopulations
African (AFR)
AF:
AC:
3279
AN:
33464
American (AMR)
AF:
AC:
5217
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
5727
AN:
26122
East Asian (EAS)
AF:
AC:
29
AN:
39686
South Asian (SAS)
AF:
AC:
14738
AN:
86240
European-Finnish (FIN)
AF:
AC:
10909
AN:
53390
Middle Eastern (MID)
AF:
AC:
1461
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
322129
AN:
1111252
Other (OTH)
AF:
AC:
14076
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
13248
26497
39745
52994
66242
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.203 AC: 30888AN: 152038Hom.: 3814 Cov.: 32 AF XY: 0.200 AC XY: 14837AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
30888
AN:
152038
Hom.:
Cov.:
32
AF XY:
AC XY:
14837
AN XY:
74350
show subpopulations
African (AFR)
AF:
AC:
4377
AN:
41478
American (AMR)
AF:
AC:
2653
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
759
AN:
3470
East Asian (EAS)
AF:
AC:
3
AN:
5162
South Asian (SAS)
AF:
AC:
836
AN:
4822
European-Finnish (FIN)
AF:
AC:
2159
AN:
10572
Middle Eastern (MID)
AF:
AC:
81
AN:
292
European-Non Finnish (NFE)
AF:
AC:
19249
AN:
67950
Other (OTH)
AF:
AC:
437
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1225
2450
3674
4899
6124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
258
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.